AUTHOR=Fan Hui-Hui , Guo Qing , Zheng Jing , Lian Yi-Zhi , Huang Shi-Shi , Sun Yue , Zou Ming , Zhu Jian-Hong , Zhang Xiong
TITLE=ALDH1A1 Genetic Variations May Modulate Risk of Parkinson’s Disease in Han Chinese Population
JOURNAL=Frontiers in Neuroscience
VOLUME=15
YEAR=2021
URL=https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2021.620929
DOI=10.3389/fnins.2021.620929
ISSN=1662-453X
ABSTRACT=
Background: Studies in animal models have suggested that aldehyde dehydrogenase 1 (encoded by ALDH1A1) protects against Parkinson’s disease (PD) by reducing toxic metabolites of dopamine. Herein we aimed to investigate whether ALDH1A1 was genetically associated with PD susceptibility in humans.
Methods: A Han Chinese population of 1,039 subjects was recruited to analyze six tag-single nucleotide polymorphisms (SNPs), followed by haplotype analyses and variants interaction analyses. Real-time PCR was used to analyze mRNA levels of ALDH1A1 in peripheral blood of 42 subjects.
Results: The tag-SNP rs7043217 of ALDH1A1 was significantly associated with PD susceptibility with the T serving as a risk allele (genotype frequency, P = 0.030; allele frequency, P = 0.013, OR = 1.258, 95% CI = 1.050–1.508). Multiple haplotypes were linked to abnormalities of PD risk, topped by a 4-SNP GGTA module in the order of rs4646547, rs1888202, rs7043217, and rs647880 (P = 9.610 × 10–8, OR = 6.420, 95% CI = 2.944–13.998). Interaction analyses showed that a simultaneous presence of the CC genotype of rs7043217 and the TT genotype of ALDH2 variant rs4767944 conferred an elevated protection against PD (P = 4.68 × 10–4, OR = 0.378, 95% CI = 0.219–0.652). The mRNA expression of ALDH1A1 showed a trend of reduction (P = 0.084) in PD patients compared to the controls.
Conclusion: Our results provide novel genetic insights into the role of ALDH1 in PD pathogenesis.